Pharmacodynamics of H1-antihistamines: From concept to reality

Clinical and Experimental Allergy Reviews

Volumn 3, Issue 3, 2003, Pages 87-89

  Frossard, N ^a  

^a INSERM   (France)

Author keywords

Antihistamine; Pharmacodynamics; Skin prick test

Indexed keywords

CETIRIZINE; EBASTINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; PLACEBO;

ALLERGY; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HUMAN; PHARMACODYNAMICS; PRICK TEST; PRIORITY JOURNAL;

EID: 0346216114     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2003.00021.x     Document Type: Conference Paper

References (18)

1. Campoli-Richards DM, Buckley MM-T, Fitton A. Cetirizine: a review of its pharmacological properties and clinical potential in allergic rhinitis, pollen induced asthma and chronic urticaria. Drugs 1990; 40:762-81.
2. Meltzer EO, Weiler JM, Widlitz MD. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97:617-26.
3. Wiseman LR, Faulds D. Ebastine: a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Drugs 1996; 51:260-77.
4. Leynadier F, Bousquet J, Murrieta M, Attali P. Efficacy and safety of mizolastine in seasonal allergic rhinitis. The Rhinase Study Group. Ann Allergy Asthma Immunol 1996; 76:163-8.
5. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1999; 83:311-7.
6. Finn AF Jr, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1999; 104:1071-8.
7. Rivest J, Despontin K, Ghys J, Rihoux JP, Lachapelle JM. Pharmacological modulation by cetirizine and ebastine of the cutaneous reactivity to histamine. Dermatologica 1991; 183: 208-11.
8. Simons FER, McMillan JL, Simons KJ. A double-blind, single dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990; 86:540-7.
9. Humphreys F, Hunter JAA. The effects of astemizole, cetirizine and loratadine on the time course of wheal and flare reactions to histamine, codeine, and antigen. Br J Dermatol 1991; 125:364-7.
10. Lever LR, Hill S, Marks R, Rosenberg R, Thompson D. Effects of cetirizine, loratadine, and terfenadine on histamine wheal and flare reactions. Skin Pharmacol 1992; 5:29-33.
11. Frossard N, Melac M, Benabdesselam O, Pauli G. Consistency of the efficacy of cetirizine and ebastine on skin reactivity. Ann Allergy Asthma Immunol 1998; 80:61-5.
12. Frossard N, Benabdesselam O, Purohit A, Mounedji N, Pauli G. Activity of ebastine 10 and 20 mg and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers. Fund Clin Pharmacol 2000; 14:409-13.
13. Purohit A, Duvernelle C, Melac M, Benabdesselam O, Pauli G, Frossard N. Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity. Eur J Clin Pharmacol 1999; 55:589-92.
14. Purohit A, Duvernelle C, Melac M, Pauli G, Frossard N. Twenty four hours activity of cetirizine and fexofenadine in the skin. Ann Allergy 2001; 86:387-92.
15. Demoly P, Bousquet J, Manderscheid JC, Dreborg S, Dhivert H, Michel FB. Precision of skin prick and puncure tests with nine methods. J Allergy Clin Immunol 1991; 88:758-62.
16. Frossard N, Walsh GM. Comparing the anti-H1 profile of second generation antihistamines. Allergy 2000; 55 (Suppl. 60): 40-5.
17. Walsh GM, Annunziato L, Frossard N, Knol K, Levander S, Nicolas JM, Taglialatela M, Tharp MD, Tillement JP, Timmerman H. New insights into the second generation antihistamines. Drugs 2001; 61:207-36.
18. Grant JA, Danielson L, Rihoux JP, DeVos C. A double-blind, single dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy volunteers. Allergy 1999; 54:700-7.